Skip to main content
. 2017 Jan 11;96(1):24–45. doi: 10.4269/ajtmh.16-84256

Table 4:

Drugs Used in North America for Systemica Antileishmanial Therapy: Adverse Events, Monitoring for Toxicity, and Mitigation Approachesb

graphic file with name tropmed-96-24-t004a.jpg

graphic file with name tropmed-96-24-t004b.jpg

graphic file with name tropmed-96-24-t004c.jpg

graphic file with name tropmed-96-24-t004d.jpg